• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物受体(RAGE)信号通路:在糖尿病性神经病变发病机制中的激活与持续作用

The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy.

作者信息

Lukic Ivan K, Humpert Per M, Nawroth Peter P, Bierhaus Angelika

机构信息

Department of Medicine I and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany.

出版信息

Ann N Y Acad Sci. 2008 Apr;1126:76-80. doi: 10.1196/annals.1433.059.

DOI:10.1196/annals.1433.059
PMID:18448798
Abstract

The molecular mechanisms underlying loss of pain perception in diabetic neuropathy are poorly understood. Experimental diabetic neuropathy models recently provided evidence that engagement of the receptor for advanced glycation end products (RAGE) and RAGE-dependent sustained activation of the proinflammatory transcription factor nuclear factor kappa B might significantly contribute to reduced nociception. Most importantly, diabetes-induced loss of pain perception is largely prevented in RAGE-deficient mice compared to RAGE-bearing wild-type mice. Identifying RAGE-dependent inflammation as one pathomechanism underlying neuronal dysfunction might provide the basis for new therapeutic approaches.

摘要

糖尿病性神经病变中痛觉丧失的分子机制尚不清楚。实验性糖尿病性神经病变模型最近提供了证据,表明晚期糖基化终末产物受体(RAGE)的激活以及RAGE依赖的促炎转录因子核因子κB的持续激活可能显著导致痛觉降低。最重要的是,与野生型RAGE小鼠相比,RAGE基因缺陷小鼠在很大程度上预防了糖尿病引起的痛觉丧失。将RAGE依赖的炎症确定为神经元功能障碍的一种发病机制,可能为新的治疗方法提供依据。

相似文献

1
The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy.晚期糖基化终末产物受体(RAGE)信号通路:在糖尿病性神经病变发病机制中的激活与持续作用
Ann N Y Acad Sci. 2008 Apr;1126:76-80. doi: 10.1196/annals.1433.059.
2
The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).晚期糖基化终末产物/晚期糖基化终末产物受体/核因子-κB信号通路可能参与糖耐量受损(IGT)患者多发性神经病的发病机制。
Exp Clin Endocrinol Diabetes. 2005 May;113(5):288-91. doi: 10.1055/s-2005-865600.
3
Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.糖尿病中痛觉丧失取决于免疫球蛋白超家族的一种受体。
J Clin Invest. 2004 Dec;114(12):1741-51. doi: 10.1172/JCI18058.
4
Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.晚期糖基化终末产物受体参与糖尿病血管生成反应受损过程。
Diabetes. 2006 Aug;55(8):2245-55. doi: 10.2337/db05-1375.
5
Role of advanced glycation end products and their receptors in development of diabetic neuropathy.晚期糖基化终末产物及其受体在糖尿病神经病变发展中的作用。
Ann N Y Acad Sci. 2005 Jun;1043:598-604. doi: 10.1196/annals.1338.067.
6
Advanced glycation end products and diabetic foot disease.晚期糖基化终末产物与糖尿病足病
Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S19-24. doi: 10.1002/dmrr.861.
7
Advanced glycation end products: sparking the development of diabetic vascular injury.晚期糖基化终末产物:引发糖尿病血管损伤的发展
Circulation. 2006 Aug 8;114(6):597-605. doi: 10.1161/CIRCULATIONAHA.106.621854.
8
Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.通过血管紧张素II 1型受体上调配体-晚期糖基化终末产物受体途径在糖尿病动脉粥样硬化发病机制中至关重要。
J Mol Cell Cardiol. 2007 Oct;43(4):455-64. doi: 10.1016/j.yjmcc.2007.07.044. Epub 2007 Jul 21.
9
RAGE in inflammation: a new therapeutic target?炎症中的晚期糖基化终末产物受体:一个新的治疗靶点?
Curr Opin Investig Drugs. 2006 Nov;7(11):985-91.
10
Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.晚期糖基化终产物内源性分泌受体的小鼠直系同源物的鉴定:结构、功能与表达
Biochem J. 2006 May 15;396(1):109-15. doi: 10.1042/BJ20051573.

引用本文的文献

1
Mitochondrial dynamics in diabetic peripheral neuropathy: Pathogenesis, progression, and therapeutic approaches.糖尿病周围神经病变中的线粒体动力学:发病机制、进展及治疗方法
Medicine (Baltimore). 2025 Jul 18;104(29):e42748. doi: 10.1097/MD.0000000000042748.
2
Glycation in Alzheimer's Disease and Type 2 Diabetes: The Prospect of Dual Drug Approaches for Therapeutic Interventions.阿尔茨海默病与2型糖尿病中的糖基化:双重药物治疗干预方法的前景
Mol Neurobiol. 2025 May 22. doi: 10.1007/s12035-025-05051-9.
3
Flavonoids regulating NLRP3 inflammasome: a promising approach in alleviating diabetic peripheral neuropathy.
黄酮类化合物调节NLRP3炎性小体:缓解糖尿病周围神经病变的一种有前景的方法。
Inflammopharmacology. 2025 Apr 9. doi: 10.1007/s10787-025-01729-7.
4
The role of AGEs in muscle ageing and sarcopenia.晚期糖基化终末产物在肌肉衰老和肌肉减少症中的作用。
Bone Joint Res. 2025 Mar 4;14(3):185-198. doi: 10.1302/2046-3758.143.BJR-2024-0252.R1.
5
Diabetic Neuropathic Pain: Directions for Exploring Treatments.糖尿病性神经病理性疼痛:探索治疗方法的方向
Biomedicines. 2024 Mar 6;12(3):589. doi: 10.3390/biomedicines12030589.
6
Fenugreek seed ethanolic extract inhibited formation of advanced glycation end products scavenging reactive carbonyl intermediates.胡芦巴籽乙醇提取物抑制晚期糖基化终产物的形成并清除活性羰基中间体。
Heliyon. 2023 Jun 1;9(6):e16866. doi: 10.1016/j.heliyon.2023.e16866. eCollection 2023 Jun.
7
Fibronectin in hyperglycaemia and its potential use in the treatment of diabetic foot ulcers: A review.高血糖症中的纤连蛋白及其在糖尿病足溃疡治疗中的潜在用途:综述。
Int Wound J. 2023 May;20(5):1750-1761. doi: 10.1111/iwj.13997. Epub 2022 Dec 19.
8
New horizons of biomaterials in treatment of nerve damage in diabetes mellitus: A translational prospective review.生物材料在治疗糖尿病性神经损伤中的新视野:转化前瞻性综述。
Front Endocrinol (Lausanne). 2022 Oct 27;13:1036220. doi: 10.3389/fendo.2022.1036220. eCollection 2022.
9
Role of RAGE in the Pathogenesis of Neurological Disorders.晚期糖基化终产物受体(RAGE)在神经退行性疾病发病机制中的作用。
Neurosci Bull. 2022 Oct;38(10):1248-1262. doi: 10.1007/s12264-022-00878-x. Epub 2022 Jun 21.
10
Electroacupuncture Alleviates Diabetic Peripheral Neuropathy by Regulating Glycolipid-Related GLO/AGEs/RAGE Axis.电针通过调节糖脂相关 GLO/AGEs/RAGE 轴缓解糖尿病周围神经病变。
Front Endocrinol (Lausanne). 2021 Jul 6;12:655591. doi: 10.3389/fendo.2021.655591. eCollection 2021.